Sign up to save your podcasts
Or
Share Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes
A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).
View all episodes
By Mark Ebell
4.7
9292 ratings
A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).
More shows like Primary Care Update
View all
JAMA Editors' Summary
140 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
505 Listeners
AFP: American Family Physician Podcast
694 Listeners
Mayo Clinic Talks
280 Listeners
Frankly Speaking About Family Medicine
254 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
JAMA Medical News
87 Listeners
Core IM | Internal Medicine Podcast
1,116 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
362 Listeners
Run the List
254 Listeners
The Curious Clinicians
367 Listeners
The Cribsiders
314 Listeners